News & Events
Latest News
Catch up on the latest blogs, press releases, publications, and other news at Indica Labs.
Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems
ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has
Multiple South West London Pathology Trusts Select Indica Labs and Leica Biosystems for Advancing Digital Pathology in Clinical Practice
With 45 pathologists and over half a million whole slide images (WSIs) produced annually, this network of London trusts deploys Aperio GT 450 DX scanners and HALO AP® to support diagnostic collaboration across multiple locations Cloud-based technology will be employed
Indica Labs’ Pharma Services Launches GCP-Compliant Image Analysis Service
Albuquerque, NM, July 8, 2025 – Indica Labs, the global leader in AI-powered digital pathology software and services, today announces that their Pharma Services team is offering quantitative image analysis studies designed and performed to Good Clinical Practice (GCP) standards.
Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI
Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67
Fetal growth restriction (FGR) is a significant concern in obstetrics, affecting 5–10% of pregnancies globally. FGR is a major contributor to perinatal morbidity and mortality and poses a significant maternal risk due to potential co-occurrence with pre-eclampsia. Despite their impact,...
Learn More
Melanoma, a highly aggressive type of skin cancer originating from pigment-producing cells called melanocytes, can be a source of diagnostic confusion for pathologists. While primary melanomas are easily recognizable, metastatic melanomas can dedifferentiate and exhibit varied and misleading cyto-architectural characteristics,...
Learn More
High-grade serous ovarian cancer (HGSC) is known to have a high degree of both genetic and immunologic heterogeneity, can be resistant to chemotherapy, and commonly recurs in patients. It is also the most common form of ovarian cancer and represents...
Learn More
Advancing Neuroscience Research with HALO® and HALO AI
As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges to traditional histological analysis.
Announcing HALO® Muscle Fiber BF and Muscle Fiber FL Modules Supporting Interactive Markups
We’re excited to announce the launch of the newly updated Muscle Fiber BF and Muscle Fiber FL modules supporting AI nuclear segmentation, AI membrane segmentation, interactive markups, and new output metrics..
Unlocking the Potential of Antibody-Drug Conjugates (ADC) with HALO® Image Analysis and Indica Labs Pharma Services
Antibody-drug conjugates (ADC) represent one of the most promising classes of next-generation cancer therapeutics, combining antibody-based targeting with the potency of chemotherapy.
HALO®, HALO AI, and HALO Link 4.2 Features and Functionalities
In this blog post, you can learn about some of the new features in the 4.2 release, when to expect your chance to upgrade, and where to find user guides, release notes, and tutorial videos.
Digital Pathology in Clinical Trials: Driving Faster Drug Development
The Clinical Trials module in HALO AP® and HALO AP Dx provides pathologists and researchers access to comprehensive digital pathology tools for building objective, unbiased datasets that support medical research and faster drug development.
HALO AP® 2.4 Features and Functionalities
Check-out exciting new features and functionalities in the latest release of HALO AP®, AI-powered digital pathology platform for diagnostics
People of Pathology Podcast: Adam Smith – Making AI Accessible For All With Indica Labs
Adam Smith shares his journey from being a HALO® customer to helping lead Indica Labs’ mission of making AI accessible to pathologists everywhere.
12 Years of Digital Pathology Innovation and What to Expect Next
Kate Lillard Tunstall discusses Indica Lab’s 12-year journey in digital pathology, the impact of AI, and the future of the industry
Advancing Neuroscience Research with HALO® and HALO AI
As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges to traditional histological analysis.
Announcing HALO® Muscle Fiber BF and Muscle Fiber FL Modules Supporting Interactive Markups
We’re excited to announce the launch of the newly updated Muscle Fiber BF and Muscle Fiber FL modules supporting AI nuclear segmentation, AI membrane segmentation, interactive markups, and new output metrics..
Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems
ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has issued a 510(k) clearance for the enterprise digital pathology platform
Unlocking the Potential of Antibody-Drug Conjugates (ADC) with HALO® Image Analysis and Indica Labs Pharma Services
Antibody-drug conjugates (ADC) represent one of the most promising classes of next-generation cancer therapeutics, combining antibody-based targeting with the potency of chemotherapy.
Indica Labs’ London HALO® User Group Meeting 2025
9 December 2025 | Indica Labs is pleased to announce our London HALO® User Group Meeting at Hilton London Metropole on 9 December from 12:00 – 16:00 Lunch will be provided to all pre-registered attendees.
Webinars and Events
Check out our upcoming and most popular webinars and events!
Indica Labs’ London HALO® User Group Meeting 2025
9 December 2025 | Indica Labs is pleased to announce our London HALO® User Group Meeting at Hilton London Metropole on 9 December from 12:00 – 16:00 Lunch will be provided to all pre-registered attendees.
Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist
Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss
Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor
Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading
Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist
Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss
Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor
Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading
All Webinars
Explore all of our upcoming and past webinars by category.
Present with Indica Labs
Interested in presenting your work using HALO software at an Indica Labs webinar or user group meeting? Fill out the form below!
You can also drop us an email at marketing@indicalab.com and let us know!